Gerald Webersinke

Linz, 4020, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Severe osteogenesis imperfecta due to homozygous glycine substitutions in COL1A1 and COL1A2.

Severe osteogenesis imperfecta due to homozygous glycine substitutions in COL1A1 and COL1A2.

Journal: European journal of endocrinology

Published: January 11, 2026

Characterization of CTNND2-related neurodevelopmental disease, phenotype-genotype spectrum and WNT dynamics in early neurogenesis.

Characterization of CTNND2-related neurodevelopmental disease, phenotype-genotype spectrum and WNT dynamics in early neurogenesis.

Journal: Research square

Published: January 08, 2026

Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis.

Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis.

Journal: Cancers

Published: October 18, 2025

Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma.

Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma.

Journal: Scientific reports

Published: September 30, 2025

NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data.

NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data.

Journal: ESMO open

Published: June 27, 2025

Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants.

Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: March 15, 2025

The ALPL gene variant project: results of the first 100 reclassified variants.

The ALPL gene variant project: results of the first 100 reclassified variants.

Journal: JBMR plus

Published: January 12, 2025

Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment.

Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment.

Journal: Cancers

Published: October 28, 2024

Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.

Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.

Journal: Cancers

Published: August 12, 2024

Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine.

Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine.

Journal: The oncologist

Published: August 01, 2024

Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.

Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.

Journal: Cancer immunology, immunotherapy : CII

Published: August 01, 2024

Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity.

Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity.

Journal: ESMO open

Published: April 01, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026